Impact of Precision Medicine in Oncology Immuno-oncology

被引：0

作者：

Buchbinder, Elizabeth I. ^{[1
,2
,3
,5
]}

Hodi, F. Stephen ^{[1
,2
,3
,4
]}

机构：

[1] Dana Farber Canc Inst, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA

[2] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med, Boston, MA USA

[3] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA

[4] Dana Farber Canc Inst, Ctr Immuno Oncol, Boston, MA USA

[5] 450 Brookline Ave, Boston, MA 02215 USA

来源：

CANCER JOURNAL | 2023年 / 29卷 / 01期

关键词：

CAR-T cell; immune checkpoint inhibition; immunotherapy; cellular therapy; cytokine; TIL therapy; INTERLEUKIN-2 HD IL-2; RENAL-CELL CARCINOMA; METASTATIC MELANOMA; T-CELLS; PD-1; CTLA-4; THERAPY; IMMUNOTHERAPY; IPILIMUMAB; BLOCKADE;

D O I：

10.1097/PPO.0000000000000641

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Cancer treatment has dramatically changed over the last decade with the development of immunotherapy. Therapies including immune cytokines, immune checkpoint inhibition, intratumoral therapies, and cellular therapies are already widely used in the oncology clinic. Active development continues in these areas and in the development of vaccines, bispecific therapies, and more refined cellular therapies. In this review, we will examine the role that immune therapy has in cancer treatment and explore areas of future development.

引用

页码：15 / 19

页数：5

共 50 条

[41] Immuno-oncology for B-cell lymphomas [J].

Choi, Yoon Seok .

BLOOD RESEARCH, 2021, 56 :70-74

[42] Immuno-Oncology New Insights into Targets and Therapies [J].

Schokrpur, Shiruyeh ;

White, Michael G. ;

Roland, Christina L. ;

Patel, Sandip Pravin .

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 33 (02) :265-278

[43] The perplexing role of immuno-oncology drugs in osteosarcoma [J].

Smrke, Alannah ;

Tam, Yuen B. ;

Anderson, Peter M. ;

Jones, Robin L. ;

Huang, Paul H. .

JOURNAL OF BONE ONCOLOGY, 2021, 31

[44] Current markers and their value in the era of immuno-oncology [J].

von Rundstedt, Friedrich-Carl ;

Necchi, Andrea .

TRANSLATIONAL ANDROLOGY AND UROLOGY, 2017, 6 (06) :1111-1116

[45] New Immuno-oncology Targets and Resistance Mechanisms [J].

Tokaz, Molly C. ;

Baik, Christina S. ;

Houghton, A. McGarry ;

Tseng, Diane .

CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (09) :1201-1218

[46] Targeting T cell activation in immuno-oncology [J].

Saibil, S. D. ;

Ohashi, P. S. .

CURRENT ONCOLOGY, 2020, 27 :S98-S105

[47] Immuno-Oncology in Hepatocellular Carcinoma: 2017 Update [J].

Kudo, Masatoshi .

ONCOLOGY, 2017, 93 :147-159

[48] Lights and Shadows in Immuno-Oncology Drug Development [J].

Bergamino Sirven, Milana ;

Pernas, Sonia ;

Cheang, Maggie C. U. .

CANCERS, 2021, 13 (04) :1-11

[49] Precision Tools in Immuno-Oncology: Synthetic Gene Circuits for Cancer Immunotherapy [J].

Bonfa, Giuliano ;

Blazquez-Roman, Juan ;

Tarnai, Rita ;

Siciliano, Velia .

VACCINES, 2020, 8 (04) :1-17

[50] Complications of immuno-oncology care: what urologist should know [J].

Grajales, Valentina ;

Martini, Alberto ;

Shore, Neal D. .

BJU INTERNATIONAL, 2024, 133 (05) :524-531

← 1 2 3 4 5 →